PTH and Marchiafava-Bignami disease: The development of mineral bone disease (MBD) is a critical issue in the chronic kidney disease (CKD) context, manifesting with an abnormal metabolism of calcium, phosphorus, parathyroid hormone (PTH), and vitamin D, impairment in bone metabolism, and soft-tissue calcifications.